Argenx
ARGX
#491
Rank
โ‚ฌ41.93 B
Marketcap
677,63ย โ‚ฌ
Share price
-0.89%
Change (1 day)
3.55%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: โ‚ฌ41.93 Billion

As of January 2026 Argenx has a market cap of โ‚ฌ41.93 Billion. This makes Argenx the world's 491th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Argenx from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ41.93 B-6.38%
2025โ‚ฌ44.79 B24.46%
2024โ‚ฌ35.98 B76.3%
2023โ‚ฌ20.41 B4.48%
2022โ‚ฌ19.53 B20.32%
2021โ‚ฌ16.23 B42.44%
2020โ‚ฌ11.39 B85.66%
2019โ‚ฌ6.14 B100.34%
2018โ‚ฌ3.06 B83.42%
2017โ‚ฌ1.67 B
2014โ‚ฌ0.11 B

End of Day market cap according to different sources

On Jan 11th, 2026 the market cap of Argenx was reported to be:

โ‚ฌ41.32 Billion
by Nasdaq info icon info icon
โ‚ฌ42.20 Billion
by CompaniesMarketCap info icon info icon